Gene therapy and biomarker/diagnostic company focused on neurological conditions including; ALS, Parkinson's, Alzheimer's and TBI.
Business primarily focused on gene therapy and biomarker/diagnostic services, with a specific emphasis on neurological conditions such as ALS, Parkinson's, Alzheimer's, and TBI.
Offers biomarker testing as a CRO for pharma and researchers. Additionally, it is involved in the development of Adeno-Associated Viruses (AAVs) for neurodegenerative disorders, with a particular focus on inflammation and targeting neurons and glial cells.
Has patented and licensed technologies from premier research institutions.
The company generates revenue on a per research project basis, with an average project duration of 3 months and an average value ranging from $8,000 to $25,000. It has successfully completed projects for 10 different research companies since its inception.
The company is currently engaged in a gene therapy research project involving 2,600 samples.
There are 2 permanent employees, additionally, we have a few temporary employees/interns as well.
0
0
0
0
0